This content is provided by Chambers. Learn more about our methodology
What the team is known for Experienced in defending high-profile targets from lawsuits filed by nonpracticing entities. Also recognized for its advice on strategy and IP issues concerning transactions. Enjoys a fine track record for its work on behalf of electronics and telecommunications clients. Also adept at prosecuting patents in the pharmaceutical space, as well as handling Hatch-Waxman litigation.
Strengths Commentators call it a "formidable group."
Work highlights Acted for Alexion Pharmaceuticals on IPR proceedings brought by Amgen challenging the patent relating to Alexion's biologic product Soliris.
Gerald Flattmann maintains a respected patent practice focusing on representation of life sciences sector clients in a range of disputes. He frequently acts on Hatch-Waxman patent litigation and IPR proceedings. "His results speak for themselves," one source notes, adding: "He has a great track record of success and is a dominant force at trial."